Cellectis S.A.

Historical 13F Holders

Symbol
CLLS
CUSIP
15117K103
All holders as of
Q2 2026
Type
Equity
Class
SPON ADS
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 15117K103 since 12/18/2024, largest first.

Filer % of Class Filed
AstraZeneca PLC 13D/A
44.0% 1/24/2025
Event 1/23/2025
Bpifrance Participations SA 13D/A
11.1% 12/12/2025
Event 12/3/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Long Focus Capital Management, LLC 13G/A
4.6% 2/11/2025
Event 12/31/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 6 35.6 k $53.7 k
2026 Q2 27 9.48 M $28.4 M
2026 Q1 32 10.2 M $32.5 M
2025 Q4 34 10.5 M $51.1 M
2025 Q3 29 8.32 M $23.7 M
2025 Q2 25 11.8 M $17.9 M
2025 Q1 28 13.6 M $16.9 M
2024 Q4 30 12.8 M $23.0 M
2024 Q3 28 9.77 M $20.9 M
2024 Q2 29 9.86 M $18.4 M
2024 Q1 32 10.0 M $26.6 M
2023 Q4 35 9.89 M $30.5 M
2023 Q3 32 11.5 M $18.1 M
2023 Q2 37 14.0 M $27.6 M
2023 Q1 35 15.2 M $29.3 M
2022 Q4 41 8.73 M $18.3 M
2022 Q3 51 10.3 M $23.6 M
2022 Q2 47 10.8 M $30.7 M
2022 Q1 54 12.4 M $56.4 M
2021 Q4 58 15.2 M $127 M
2021 Q3 71 15.4 M $194 M
2021 Q2 79 16.3 M $253 M
2021 Q1 82 15.3 M $310 M
2020 Q4 91 16.4 M $464 M
2020 Q3 76 14.3 M $264 M
2020 Q2 80 13.9 M $247 M
2020 Q1 68 15.7 M $145 M
2019 Q4 61 13.2 M $227 M
2019 Q3 65 13.1 M $137 M
2019 Q2 70 13.9 M $217 M
2019 Q1 63 12.7 M $234 M
2018 Q4 67 11.5 M $191 M
2018 Q3 82 11.5 M $326 M
2018 Q2 86 11.3 M $319 M
2018 Q1 69 7.07 M $223 M
2017 Q4 58 7.31 M $213 M
2017 Q3 43 5.87 M $167 M
2017 Q2 41 5.26 M $136 M
2017 Q1 41 5.74 M $138 M
2016 Q4 38 5.80 M $98.2 M
2016 Q3 38 6.64 M $160 M
2016 Q2 38 6.96 M $185 M
2016 Q1 44 6.47 M $178 M
2015 Q4 48 7.05 M $219 M
2015 Q3 43 7.10 M $187 M
2015 Q2 40 6.60 M $238 M
2015 Q1 44 6.12 M $212 M